Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease

Journal of Endovascular Therapy

Volumn 21, Issue 3, 2014, Pages 381-388

  Miura, Takashi ^a   Soga, Yoshimitsu ^b   Miyashita, Yusuke ^a   Iida, Osamu ^c   Kawasaki, Daizo ^d   Hirano, Keisuke ^e   Suzuki, Kenji ^f   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^f SENDAI KOUSEI HOSPITAL   (Japan)

Author keywords

Balloon angioplasty; Complications; Endovascular therapy; Hematoma; Iliac artery; Intermittent claudication; Mortality; Occlusion; Outcome analysis; Peripheral artery disease; Stenosis; Stent; Superficial femoral artery

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

ABOVE KNEE AMPUTATION; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL CRYSTAL EMBOLIZATION; CORONARY ARTERY DISEASE; DIALYSIS; DISTAL EMBOLIZATION; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEMATOMA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; ILIAC LESION; ILIOFEMORAL ARTERY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTERMITTENT CLAUDICATION; KIDNEY DYSFUNCTION; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SUPERFICIAL FEMORAL ARTERY LESION; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMORAL ARTERY; ILIAC ARTERY; JAPAN; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CONSTRICTION, PATHOLOGIC; DISEASE-FREE SURVIVAL; FEMALE; FEMORAL ARTERY; HUMANS; ILIAC ARTERY; INTERMITTENT CLAUDICATION; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903165160     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/13-4618R.1     Document Type: Article

References (25)

1. Norgren L, Hiatt ER, Dormandy JA, et al; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007;26:81-157.
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/ AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J Am Coll Cardiol. 2006;47:1239-1312.
3. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992; 326:381-386.
4. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19: 538-545. (Pubitemid 29135153)
5. Soga Y, Iida O, Kawasaki D, et al; REAL-AI investigators. Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J. 2012;76:2697-2704.
6. Soga Y, Iida O, Hirano K, et al. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg. 2010;52:608-615.
7. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD) TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
8. Bhatt DL, Steg PG, Ohman EM, et al REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180-189. (Pubitemid 43076437)
9. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg. 1999;12:123-137. (Pubitemid 29259200)
10. Hu F, Yang Y, Qiao S, et al. Comparison between radial and femoral approach for percutaneous coronary intervention in patients aged 80 years or older. J Interv Cardiol. 2012; 25:513-517.
11. Dagenais GR, Yusuf S, Bourassa MG, et al HOPE Investigators. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation. 2001;104:522-526. (Pubitemid 32738119)
12. Pfeffer MA, McMurray JJ, Velazquez EJ, et al Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893-1906. (Pubitemid 37409706)
13. Cannon CP, Braunwald E, McCabe CH, et al Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350: 1495-1504. (Pubitemid 38477774)
14. Ridker PM, Danielson E, Fonseca FA, et al JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.
15. Jamerson K, Weber MA, Bakris GL, et al ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428.
16. Keeling AN, Naughton PA, O'Connell A, et al. Does percutaneous transluminal angioplasty improve quality of life? J Vasc Interv Radiol. 2008;19:169-176.
17. Giugliano G, Di Serafino L, Perrino C, et al. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. Int J Cardiol. 2013;167:2566-2571.
18. Cook TA, O'Regan M, Galland RB. Quality of life following percutaneous transluminal angioplasty for claudication. Eur J Vasc Endovasc Surg. 1996;11:191-194. (Pubitemid 26120473)
19. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
20. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-2497.
21. Husmann M, Dorffler-Melly J, Kalka C, et al. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. J Vasc Surg. 2008;48:1211-1216.
22. Brevetti G, Schiano V, Chiariello M. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis. 2008;197:1-11.
23. Harris LM, Faggioli GL, Shah R, et al. Vascular reactivity in patients with peripheral vascular disease. Am J Cardiol. 1995;76:207-212.
24. Gokce N, Keaney JF, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105:1567-1572. (Pubitemid 34297634)
25. McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301:165-174.